| O.1 | Approve Consolidated Financial Statements and Statutory Reports | For |
| O.2 | Approve Financial Statements | For |
| O.3 | Approve the Dividend | For |
| O.4 | Approve Auditors' Special Report on Related-Party Transactions Mentioning the Absence of New Transactions | For |
| O.5 | Approve Remuneration Policy of Chairman of the Board | For |
| O.6 | Approve Remuneration Policy | Oppose |
| O.7 | Approve Compensation of Lorenzo Bini Smaghi, Chairman of the Board | For |
| O.8 | Approve Compensation of Frederic Oudea, CEO | Oppose |
| O.9 | Approve Compensation of Severin Cabannes, Vice-CEO | Oppose |
| O.10 | Approve Compensation of Bernardo Sanchez Incera, Vice-CEO | Oppose |
| O.11 | Approve Compensation of Didier Valet, Vice-CEO | Oppose |
| O.12 | Approve the Aggregate Remuneration Granted in 2017 to Certain Senior Management, Responsible Officers and Risk-Takers | Oppose |
| O.13 | Reelect Lorenzo Bini Smaghi as Director | For |
| O.14 | Elect Jerome Contamine as Director | For |
| O.15 | Elect Diane Cote as Director | For |
| O.16 | Approve Remuneration of Directors in the Aggregate Amount of EUR 1.7 Million | Oppose |
| O.17 | Appoint the Auditors | Oppose |
| O.18 | Renew Appointment of Deloitte and Associes as Auditor | For |
| O.19 | Authorise Share Repurchase | Oppose |
| E.20 | Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights up to Aggregate Nominal Amount of EUR 333.2 Million and/or Capitalization of Reserves of up to EUR 550 Million | For |
| E.21 | Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 100.98 Million | Oppose |
| E.22 | Approve Issue of Shares for Contribution in Kind | For |
| E.23 | Authorize Issuance of Convertible Bonds for Private Placements without Preemptive Rights, up to Aggregate Nominal Amount of EUR 100.98 Million | Oppose |
| E.24 | Approve Issue of Shares for Employee Saving Plan | For |
| E.25 | Authorize up to 1.4 Percent of Issued Capital for Use in Restricted Stock Plans Reserved for Regulated Persons | Oppose |
| E.26 | Authorize up to 0.6 Percent of Issued Capital for Use in Restricted Stock Plans Reserved for, Employees Excluding Regulated Persons | Oppose |
| E.27 | Authorise Cancellation of Treasury Shares | For |
| E.28 | Authorize Filing of Required Documents/Other Formalities | For |
